The association between four SNPs (rs7482144, rs4671393, rs28384513 and rs4895441) and fetal hemoglobin levels in Chinese Zhuang β-thalassemia intermedia patients.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Blood Cells, Molecules & Diseases

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bcmd.2017.01.011PMID 28160732
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription

  2016cited by this paper
• 2p15-p16.1 microdeletions encompassing and proximal to BCL11A are associated with elevated HbF in addition to neurologic impairment.

  2015cited by this paper
• Screening of Transcription Factors Involved in Fetal Hemoglobin Regulation Using Phylogenetic Footprinting

  2015cited by this paper
• Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.

  2015cited by this paper
• BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations.

  2015cited by this paper
• Variability of hemoglobin F expression in hemoglobin EE disease: hematological and molecular analysis.

  2014cited by this paper
• KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia.

  2014cited by this paper
• DNA polymorphisms at BCL11A, HBS1L-MYB and Xmn1-HBG2 site loci associated with fetal hemoglobin levels in sickle cell anemia patients from Northern Brazil.

  2014cited by this paper
• HbA2 levels in normal adults are influenced by two distinct genetic mechanisms

  2013cited by this paper
• Disruption of the Hbs1l-Myb Locus Causes Hereditary Persistence of Fetal Hemoglobin in a Mouse Model

  2013cited by this paper
• HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers.

  2013cited by this paper
• Seventy-five genetic loci influencing the human red blood cell

  2012cited by this paper
• Genetic modifiers of sickle cell disease

  2012cited by this paper
• Fetal hemoglobin in sickle cell anemia: Molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans

  2012cited by this paper
• Molecular Spectrum of α- and β-Globin Gene Mutations Detected in the Population of Guangxi Zhuang Autonomous Region, People's Republic of China

  2011cited by this paper
• Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia.

  2011cited by this paper
• MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13

  2011cited by this paper
• Influences of Genetic Variation on Fetal Hemoglobin

  2011cited by this paper
• The molecular basis of beta-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity

  2010cited by this paper
• Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China

  2010cited by this paper
• Genetic modifiers of Hb E/β0 thalassemia identified by a two-stage genome-wide association study

  2010cited by this paper
• Discovering the genetics underlying foetal haemoglobin production in adults

  2009cited by this paper
• Developmental and species-divergent globin switching are driven by BCL11A

  2009cited by this paper
• Soluble endothelial adhesion molecules and inflammation markers in patients with beta-thalassemia intermedia.

  2009cited by this paper
• Disorders of hemoglobin: Genetics, pathophysiology, and clinical management, second edition

  2009cited by this paper
• DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease

  2008cited by this paper
• MYB function in normal and cancer cells

  2008cited by this paper
• BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies.

  2008cited by this paper
• Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A

  2008cited by this paper
• Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults

  2007cited by this paper
• A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15

  2007cited by this paper
• cMYB is involved in the regulation of fetal hemoglobin production in adults.

  2006cited by this paper
• The genetics of variation in gene expression

  2002cited by this paper
• Inherited haemoglobin disorders: an increasing global health problem.

  2001cited by this paper
• Phenotype—genotype relationships in monogenic disease: lessons from the thalassaemias

  2001cited by this paper
• Genetic influences on F cells and other hematologic variables: a twin heritability study.

  2000cited by this paper
• Beta‐thalassaemia intermedia: is it possible consistently to predict phenotype from genotype?

  1998cited by this paper
• Mortality in sickle cell disease. Life expectancy and risk factors for early death.

  1994cited by this paper

• Are Mitochondria a Potential Target for Treating β-Thalassemia?

  2025cites this paper
• Rapid detection of genetic modifiers of β-thalassemia based on MALDI-TOF MS

  2025cites this paper
• Association Between KLF1, BCL11A and HBS1L‐MYB Polymorphisms and Phenotypes With β‐Thalassemia Patients in Hainan

  2025cites this paper
• Assessing the impact of HBB gene polymorphisms on the risk of beta thalassemia in the population of Diyala Governorate, Iraq

  2024cites this paper
• Disease-Modifying Effect of HBS1L-MYB in HbE/β-Thalassemia Patients in Bangladeshi Population

  2024influential citation
• Foetal haemoglobin elevation, unfavourable prognosis, and protective role of genetic variants HBG2 rs7482144, HBS1L-MYB rs9399137 and BCL11A rs4671393 in children with ALL

  2024influential citation
• Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease

  2024cites this paper
• Significance of genetic modifiers of hemoglobinopathies leading towards precision medicine

  2021cites this paper
• Insight of fetal to adult hemoglobin switch: Genetic modulators and therapeutic targets.

  2021cites this paper
• The Effect of Five Single Nucleotide Polymorphisms on Hb F Variation of β-Thalassemia Traits and Hematologically Normal Individuals in Southeast Turkey

  2020cites this paper
• Comprehensive analysis of mitochondrial and nuclear DNA variations in patients affected by hemoglobinopathies: A pilot study

  2020cites this paper
• Association Between Genetic Polymorphisms and Hb F Levels in Heterozygous β-Thalassemia 3.5 kb Deletions

  2020cites this paper
• The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients.

  2020cites this paper
• Multi-Locus Models to Address Hb F Variability in Portuguese β-Thalassemia Carriers

  2020cites this paper
• Quantitative Trait Loci Influencing Hb F Levels in Southern Thai Hb E (HBB: c.79G>A) Heterozygotes

  2018cites this paper
• Study on the Role of Polymorphisms of the SOX-6 and MYB Genes and Fetal Hemoglobin Levels in Sicilian Patients with β-Thalassemia and Sickle Cell Disease

  2018cites this paper